Lumateperone and lemborexant March 9, 2020 From The Carlat Psychiatry Report Issue Links: Learning Objectives | Editorial Information | PDF of Issue The antipsychotic lumateperone (Caplyta) and the hypnotic lemborexant (Dayvigo) are the newest in their class. Both of them claim to improve on the safety of older medications, and we look at the data to see how those claims hold up.Read More
General PsychiatryThe Adderall ShortageAdderall is in short supply, and the backlog is having a domino effect on other stimulants. Find out why, and how long it will last.Listen now